THR NUMBER 23 LIMITED

Active London

Activities of real estate investment trusts

0 employees website.com
Activities of real estate investment trusts
T

THR NUMBER 23 LIMITED

Activities of real estate investment trusts

Founded 24 Sept 2018 Active London, United Kingdom 0 employees website.com
Activities of real estate investment trusts
Accounts Submitted 14 Mar 2026 Next due 31 Mar 2026 2 months overdue
Confirmation Submitted 25 Sept 2025 Next due 7 Oct 2026 4 months remaining
Net assets £1 £0 2025 year on year
Total assets £1 £0 2025 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

Level 4, Dashwood House 69 Old Broad Street London EC2M 1QS United Kingdom

Full company profile for THR NUMBER 23 LIMITED (11585158), an active company based in London, United Kingdom. Incorporated 24 Sept 2018. Activities of real estate investment trusts. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2019–2025)

Cash in Bank

N/A

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Kenneth Macangus MackenzieDirectorBritishScotland7624 Sept 2018Active
Target Fund Managers LimitedCorporate-secretaryUnited KingdomUnknown7 Aug 2019Active

Shareholders

Shareholders (1)

Target Healthcare Reit Ltd
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 7 Aug 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Ceased

Group Structure

Group Structure

THR NUMBER 23 LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 Mar 2026AccountsAnnual accounts made up to 30 Jun 2025
25 Sept 2025Confirmation StatementConfirmation statement made on 23 Sept 2025 with no updates
15 Jun 2025OfficersTermination of Gordon Stanley Bland as director on 4 Jun 2025
15 Jun 2025OfficersAppointment of Mr James Kenneth Mackenzie as director on 4 Jun 2025
30 Jan 2025AccountsAnnual accounts made up to 30 Jun 2024
14 Mar 2026 Accounts

Annual accounts made up to 30 Jun 2025

25 Sept 2025 Confirmation Statement

Confirmation statement made on 23 Sept 2025 with no updates

15 Jun 2025 Officers

Termination of Gordon Stanley Bland as director on 4 Jun 2025

15 Jun 2025 Officers

Appointment of Mr James Kenneth Mackenzie as director on 4 Jun 2025

30 Jan 2025 Accounts

Annual accounts made up to 30 Jun 2024

Recent Activity

Latest Activity

Annual accounts made up to 30 Jun 2025

2 months ago on 14 Mar 2026

Confirmation statement made on 23 Sept 2025 with no updates

7 months ago on 25 Sept 2025

Termination of Gordon Stanley Bland as director on 4 Jun 2025

11 months ago on 15 Jun 2025

Appointment of Mr James Kenneth Mackenzie as director on 4 Jun 2025

11 months ago on 15 Jun 2025

Annual accounts made up to 30 Jun 2024

1 years ago on 30 Jan 2025